Clinical Ophthalmology (May 2018)

Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]

  • Nichols KK,
  • Holland E,
  • Toyos MM,
  • Peace JH,
  • Majmudar P,
  • Raychaudhuri A,
  • Hamdani M,
  • Roy M,
  • Shojaei A

Journal volume & issue
Vol. Volume 12
pp. 913 – 914

Abstract

Read online

Nichols KK, Holland E, Toyos MM, et al. Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial. Clin Ophthalmol. 2018;12:263–270.On page 266, both mentions of Figure 3, should be Figure 4. On page 267, Figure 4 is drawn incorrectly.Read the original article.